HUP9901674A2 - Új gyógyszerkombináció - Google Patents

Új gyógyszerkombináció

Info

Publication number
HUP9901674A2
HUP9901674A2 HU9901674A HUP9901674A HUP9901674A2 HU P9901674 A2 HUP9901674 A2 HU P9901674A2 HU 9901674 A HU9901674 A HU 9901674A HU P9901674 A HUP9901674 A HU P9901674A HU P9901674 A2 HUP9901674 A2 HU P9901674A2
Authority
HU
Hungary
Prior art keywords
active ingredient
extract
subject
pharmaceutical combination
salt
Prior art date
Application number
HU9901674A
Other languages
English (en)
Inventor
Jan Trofast
Anders Ullman
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of HUP9901674A2 publication Critical patent/HUP9901674A2/hu
Publication of HUP9901674A3 publication Critical patent/HUP9901674A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A találmány tárgyát képező kőmbináció keverék főrmájában (a) első hatóanyagként főrmőterőlt, annak gyógyászatilag elfőgadhatósóját vagy szőlvátját, vagy egy ilyen só szőlvátját; és (b) másődik hatóanyagként bűdesőnidőt; tővábbá gyógyászatilagelfőgadható adalék-, hígító- vagy vivőanyagőt tartalmaz, és ahatóanyagőt mőláris aránya 1 : 30 és 1 : 36 közé eső érték, előnyösenez az arány 1 : 32,5. A kőmbinációt célszerűen finőm előszlásúpőrkeverék főrmájában állítják elő, és inhalálással adják légzésirendellenességben szenvedő pácienseknek. A találmány tárgyát képeziegy őlyan készlet is, amelyben a hatóanyagők külön-külön edénybenvannak elhelyezve. ŕ
HU9901674A 1996-10-08 1997-09-24 New pharmaceutical combination HUP9901674A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9603669A SE9603669D0 (sv) 1996-10-08 1996-10-08 New combination

Publications (2)

Publication Number Publication Date
HUP9901674A2 true HUP9901674A2 (hu) 1999-09-28
HUP9901674A3 HUP9901674A3 (en) 2001-04-28

Family

ID=20404167

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901674A HUP9901674A3 (en) 1996-10-08 1997-09-24 New pharmaceutical combination

Country Status (18)

Country Link
EP (1) EP0871450A1 (hu)
JP (1) JP2000502365A (hu)
KR (1) KR19990071975A (hu)
AR (1) AR013614A1 (hu)
AU (1) AU715319B2 (hu)
BR (1) BR9706822A (hu)
CA (1) CA2239308A1 (hu)
CZ (1) CZ176198A3 (hu)
HU (1) HUP9901674A3 (hu)
MY (1) MY128337A (hu)
NO (1) NO982414D0 (hu)
NZ (1) NZ330482A (hu)
PL (1) PL327037A1 (hu)
SE (1) SE9603669D0 (hu)
SK (1) SK75198A3 (hu)
TW (1) TW470647B (hu)
WO (1) WO1998015280A1 (hu)
ZA (1) ZA978889B (hu)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9700136D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700134D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
TR199903272T2 (xx) * 1997-06-27 2000-08-21 Astra Aktiebolag Ast�m kar��t� ila�lar�n yeni bile�imleri.
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) * 1998-06-11 1998-06-11 Astra Ab New use
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
SE9900834D0 (sv) * 1999-03-09 1999-03-09 Astra Ab Novel combination
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012260D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
FI20002216A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
SE527069C2 (sv) 2003-06-19 2005-12-13 Mederio Ag Förfarande och anordning för administrering av läkemedelspulver
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050026887A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
IN2014MN00380A (hu) 2006-06-30 2015-06-19 Iceutica Pty Ltd
KR20090121338A (ko) 2007-02-19 2009-11-25 씨아이피엘에이 엘티디. 두 개 이상의 기관지확장제 또는 기관지확장제와 코르티코스테로이드의 약제학적 조합
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
CA2763939A1 (en) 2009-05-29 2010-12-02 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting b2 adrenergic receptor agonists and associated methods and systems
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CA2865702C (en) 2012-02-28 2020-04-28 Iceutica Holdings Inc. Bvi Inhalable pharmaceutical compositions
ITMI20130571A1 (it) 2013-04-10 2014-10-11 Zambon Spa Composizione farmaceutica contenente budesonide e formoterolo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2356145A1 (en) * 1991-12-18 1993-06-24 Aktiebolaget Astra New combination of formoterol and budesonide

Also Published As

Publication number Publication date
JP2000502365A (ja) 2000-02-29
BR9706822A (pt) 1999-03-23
EP0871450A1 (en) 1998-10-21
TW470647B (en) 2002-01-01
MY128337A (en) 2007-01-31
NO982414L (no) 1998-05-27
ZA978889B (en) 1998-04-08
NZ330482A (en) 1999-11-29
WO1998015280A1 (en) 1998-04-16
PL327037A1 (en) 1998-11-09
NO982414D0 (no) 1998-05-27
CZ176198A3 (cs) 1998-09-16
KR19990071975A (ko) 1999-09-27
AU715319B2 (en) 2000-01-20
HUP9901674A3 (en) 2001-04-28
CA2239308A1 (en) 1998-04-16
SE9603669D0 (sv) 1996-10-08
AR013614A1 (es) 2001-01-10
AU4578297A (en) 1998-05-05
SK75198A3 (en) 1998-11-04

Similar Documents

Publication Publication Date Title
HUP9901674A2 (hu) Új gyógyszerkombináció
IL150986A0 (en) 1,2,3,4,- tetrahydroisoquinoline derivatives
AU2001241631A1 (en) Compositions suitable for oral administration and kits and methods thereof for hydrating mammalian skin
GB0004128D0 (en) Novel compounds
IL157093A0 (en) 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
HUP0301892A2 (hu) Szexuális zavarok kezelésére szolgáló gyógyszerkészítmények és előállításuk
BR0007539A (pt) Composição para o tratamento curativo e profilático da obesidade, utilização de um extrato de chá verde ou de um pó de chá verde, e, processo de tratamento estético de um ser humano para melhorar sua silhueta
HUP0301349A2 (hu) IL-11-tartalmú készítmények
ZA98214B (en) Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1.
GR3007385T3 (hu)
HUP0100539A2 (hu) D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására
WO2002070464A3 (en) Hydrazones and their therapeutic use
BG106155A (en) Novel derivatives and analogues of galanthamin
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
MD20020265A (en) Calcium-containing pharmaceutical composition
HUP9900978A2 (hu) Dioszgenint tartalmazó készítmény
MXPA03000430A (es) Nuevas arileteno-sulfonamidas.
MY134019A (en) Aryl oxime-piperazines useful as ccr5 antagonists
BR9911005A (pt) Uso de ozÈnio para a preparação de medicamentos para o tratamento de cáries dentárias
HUP0002533A2 (hu) Asztmaellenes gyógyszerhatóanyagok új kombinációja
ATE59295T1 (de) Prazosin-pirbuterol-mischung zur bronchendilatation.
EP0373771A3 (en) New pharmaceutical uses for cystatins
BG106151A (en) Pharmaceutical complex

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees